申请人:SmithKline Beecham Intercredit B.V.
公开号:US05409943A1
公开(公告)日:1995-04-25
The present invention relates to N-pyridylamidine and N-pyridylguanidine derivatives of general formula (I) in which: Ar.sup.1 is an optionally substituted phenyl ring; Ar.sup.2 is an optionally substituted phenyl ring; R.sup.1 is hydrogen or C.sub.1-4 alkyl; R.sup.2 is hydrogen or C.sub.1-4 alkyl; R.sup.3 is hydrogen or C.sub.1-4 alkyl; R.sup.4 is hydrogen, halogen, C.sub.1-6 alkyl or C.sub.1-6 alkoxy; X is CH.sub.2 or NR.sup.5, and R.sup.5 is hydrogen or C.sub.1-4 alkyl, and the salts thereof, and their use in therapy as gastric acid secretion inhibitors.
本发明涉及一般式(I)中的N-吡啶基脲和N-吡啶基胍衍生物,其中:Ar.sup.1是可选取代的苯环;Ar.sup.2是可选取代的苯环;R.sup.1是氢或C.sub.1-4烷基;R.sup.2是氢或C.sub.1-4烷基;R.sup.3是氢或C.sub.1-4烷基;R.sup.4是氢、卤素、C.sub.1-6烷基或C.sub.1-6烷氧基;X是CH.sub.2或NR.sup.5,而R.sup.5是氢或C.sub.1-4烷基。本发明的盐及其在治疗中作为胃酸分泌抑制剂的用途也被揭示。